Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria

Ceftobiprole is the first broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA) to be assessed in late-stage clinical trials. As a pivotal step in the clinical development of ceftobiprole, a multicenter, global, randomized, double-blind trial was condu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Noel, Gary J., Strauss, Richard S., Amsler, Karen, Heep, Markus, Pypstra, Rienk, Solomkin, Joseph S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2008
Aiheet:
Clinical Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2223887/
https://ncbi.nlm.nih.gov/pubmed/17954698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00551-07
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia